This site is intended for healthcare professionals
News

Adamis Pharmaceuticals receives a Complete Response Letter from the FDA regarding Zimhi for the treatment of opioid overdose.

Read time: 1 mins
Last updated:17th Nov 2020
Published:17th Nov 2020
Condition: Opioid Dependence/Overdose
Type: drug
Register free for full access to medthority.com